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Objective
To report the first application of ex vivo fluorescence confocal
microscopy (FCM) - a novel optical technology that is
capable of providing fast microscopic imaging of unfixed
tissue specimens- in the urological field assessing its
diagnostic accuracy for non neoplastic and cancerous prostate
tissue (prostatic adenocarcinoma) compared to the 'gold
standard' histopathological diagnoses.
Patients and methods
In all, 89 specimens from 13 patients with clinically localised
prostate cancer were enrolled into the study. All patients
underwent robot-assisted laparoscopic radical prostatectomy
with fresh prostatic tissue biopsies taken at the end of each
intervention using an 18-G biopsy punch. Specimens were
randomly assigned to the three collaborating pathologists for
evaluation. Intra- and inter-observer agreement was tested by
the means of Cohen’s j. The diagnostic performance was
evaluated on receiver operating characteristic curve analysis.
Results
The overall diagnostic agreement between FCM and
histopathological diagnoses was substantial with a 91%
correct diagnosis (j = 0.75) and an area under the curve of
0.884 (95% confidence interval 0.840–0.920), 83.33%
sensitivity, and 93.53% specificity.
Conclusion
FCM seems to be a promising tool for enhanced specimens’
reporting performance, given its simple application and very
rapid microscopic image generation (<5 min/specimen). This
technique may potentially be used for intraoperative
pathological specimens’ analysis.
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Prostate cancer is the most commonly diagnosed male cancer
worldwide [1] and its management is a delicate balance
between optimum postoperative functional outcomes and
oncological radicalness [2]. Several recent diagnostic and
managerial innovations have been introduced, including
multiparametric MRI (mpMRI), mpMRI-ultrasonography
fusion targeted biopsy, neurovascular bundle-sparing radical
prostatectomy (RP) technique, and robot-assisted laparoscopic
approach to RP (RALP) [3–5].
However, the ‘gold standard’ pathological assessment of
prostate cancer is still a conventional, time-consuming
approach [6]. Moreover, a cancer-free surgical margin is
considered a critical part of prostate cancer surgery, as
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positive surgical margins (PSMs) can be found in up to 38%
of patients after RP [1,7]. PSM is one of the major ‘surgically
controlled’ concerns of RP, as it is associated with an
increased risk of recurrence, the need for adjuvant therapy,
and increased management costs [1,6].
The concept of ‘real-time’ pathological examinations [6,8,9]
initially appeared in the late 1800s, with the first report of the
‘intraoperative frozen section’ technique in 1895 [10]. After
>120 years, this technique is still the gold standard real-time
pathological assessment, despite debatable results [6,8,9].
A potential new method of real-time prostate cancer tissue
evaluation is ex vivo fluorescence confocal microscopy (FCM).
FCM provides optical microscopic images of freshly excised
tissue in two different modalities; the reflectance mode, based
upon different refractive indices of subcellular structures, and
the fluorescence mode, using fluorescent agents to increase
the contrast within epithelium-stroma of untreated ex vivo
specimens. It has mainly been applied to the diagnoses of
dermatological cancers, such as basal cell and squamous cell
carcinomas [11,12]. Preliminary research into FCM as a
diagnostic tool for other visceral organ cancers seems
promising [13]. Furthermore, it showed to be a promising
tool for diagnosis of cutaneous inflammatory skin lesions
[14].
Some previously cited FCM technical limitations have
recently been overcome through increasing three-fold the field
of acquisition and the velocity with which it is acquired, and
improving digital staining processing (transforming previous
black and white images into coloured images that is able to
mimic haematoxylin and eosin [H&E] staining). The
advantage of FCM compared to histological examinations is
primarily time; the procedure is performed within a few
minutes, directly at the patient bedside. Further, the quality of
FCM images, produced on a cellular and even nuclear level,
have an H&E-like appearance and resolution and the
application of FCM evaluation does not compromise tissue
for further conventional pathological assessment [15].
Aim of the work
Based upon the benefits of FCM, i.e., faster diagnosis in
different surgical settings, we hypothesised that such
advantages are transferrable to urology, choosing to
investigate firstly prostate cancer due to its widespread
diffusion. In the present preliminary analysis, we aimed to
explore the feasibility of FCM in the examination of prostatic
tissues (diagnostic discrimination of FCM imaging for
non-neoplastic and cancerous prostate tissue [prostatic
adenocarcinoma] compared to the gold standard
histopathological diagnoses). We intentionally chose fresh
specimens from RP for the increased probability of the
presence of malignant tissue in such samples already
diagnosed with prostate cancer.
Patients and methods
Study type and patients recruitment
This single-centre prospective study was approved by the local
Ethics Committee (Protocol 0018091/18) and was carried out
according to the Declaration of Helsinki. Written informed
consent was provided by all participating patients. Consecutive
patients undergoing RALP for low-, medium- or high-risk
prostate cancer were enrolled. All procedures were carried out
by two expert surgeons (G.B., B.R.) with the da Vinci
Surgical System (Intuitive Surgical, Inc., Sunnyvale, CA, USA).
Preoperative, intraoperative, pathological and follow-up data
were collected and stored in an electronic database.
Study endpoints
The study’s primary outcome was to assess the level of
agreement between FCM evaluation and histopathological
diagnosis of prostatic specimens. Secondary endpoints
included the level of agreement for the identification of
typical malignancy features at FCM and histopathological
evaluation, the level of confidence of digital imaging
interpretation, as assessed by the collaborating pathologists,
and the assessment of inter-observer reliability.
Biopsy preparation
Using an 18-G biopsy punch, an average of six random prostate
biopsies (range four to eight) were freshly acquired at the end of
each intervention. Biopsies were immediately treated with a
staining process; tissue specimens were completely immersed in
acridine orange solution (0.6 mM; Sigma-Aldrich, St. Louis, MO,
USA) ) for 30 s before being rinsed in physiological saline
solution to wash off any excess solution. The samples were
placed on absorbent paper, and then embedded between two
glass slides, fixed with silicon glue. Glass sandwiches were then
positioned onto the FCM stage for image acquisition. FCM
images were then saved on a dedicated hard disk, according to a
patient identification number and intervention date.
Instrument
The FCM VivaScope 2500M-G4 (MAVIG GmbH, Munich,
Germany; Caliber I.D.; Rochester, NY, USA) combines two
different lasers that enable tissue examination according to
reflectance (785 nm) and fluorescence (488 nm) modalities. The
FCM device has a vertical resolution of 4 lm and a maximum
examination depth of 200 lm. Increasing the laser power and/or
the incubation period of the specimen in the staining solution
allows mechanical amplification of the fluorescence and
reflectance signals resulting in possible visualisation of deeper
structures. Furthermore, as the specimens are glued to glass
slides in a sandwich technique, the two sides of the glass
sandwich can be examined by the FCM allowing better
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evaluation of the deeper side of the specimen. Magnification
reaches 9 550 and the reconstructed image is a collection of
mosaic images (square shaped images of 1024 9 1024 pixels).
The maximum total scan area is 25 9 25 mm; however, larger
tissues can be examined by cutting it into multiple specimens.
The microscope is equipped with a 389 water immersion
objective with a numerical aperture of 0.85 [16]. For the present
study, the FCM incorporated software, VivaScan (version
11.0.1140 MAVIG GmbH; Caliber I.D.), VivaBlock and
VivaStack were used to obtain tissue images. The digital
staining modality was used to convert the reflectance and
fluorescence greyscale mosaics into colour images. For the
present study, a new modality of pixel coloration by self-written
ImageJ software (https://imagej.nih.gov/ij/) was applied to the
standard digital image approach; [17] each greyscale pixel is
converted into a digitally stained image, in which nuclei appear
purple and collagen and cytoplasm appear pink. The reflectance
and fluorescence brightness in FCM images are inverted to the
absorbance-based contrast, as is performed in histopathology
imaging. Zoom capabilities enable an enhanced visualisation of
cell morphology details.
The staining and imaging processes were completed within
5 min. After the acquisition of FCM images, stained samples
were formalin fixed in a biopsy container (Biopsafe ApS;
Bygstubben, Denmark) and sent for histopathological
evaluation.
Sample examinations
Three pathologists with various levels of expertise (L.R.B.,
A.M. and R.M.) participated in the study. All acquired FCM
images were randomly displayed to collaborating pathologists
prior to proceeding to the histopathological diagnosis. The
pathologists were instructed to independently identify the
presence of four typical malignancy features (atypical glands,
enlarged nuclei, prominent nucleoli, and infiltrative pattern of
glandular growth) and to differentiate between cancerous and
non-neoplastic tissue (FCM evaluation). Furthermore, they
were instructed to express their degree of confidence with the
digital imaging interpretation (scale ranging from zero to
100).
The prepared prostatic tissue samples were evaluated by the
same three pathologists for the presence of the same four
typical malignancy features. A final histopathological
diagnosis was then made and in case of disagreement
between the three pathologists, the histopathological diagnosis
reached by the majority was considered final.
Statistical analysis
The Cohen’s j statistic was used to measure the agreement
between the FCM and histopathological diagnoses, and for
the presence of typical malignancy features identified at FCM
and histopathology evaluations, as the variables are binary
[18]. Inter-observer agreement was evaluated for FCM
evaluation in relation to histopathological diagnosis. The
adopted interpretation of agreement includes: a less than
chance agreement (j = 0), slight agreement (j = 0.01–0.20),
fair agreement (j = 0.21–0.40), moderate agreement
(j = 0.41–0.60), substantial agreement (j = 0.61–0.80), and
almost perfect agreement (j = 0.81–0.99). Furthermore, the
adopted interpretation of reproducibility includes: marginal
(j <0.40), good (j = 0.40–0.75), and excellent (j ˃0.75) [19].
Pearson correlation coefficient was used to measure the
correlation between the level of confidence of the pathologists
in FCM diagnosis and the gold standard.
Table 1 FCM evaluation of prostatic biopsies compared to histopathological diagnoses, the percentage of correct diagnoses, j-value and significance
for all raters and each operator.








Prostatic acinar adenocarcinoma 55 11 91 0.75*** Substantial
Non-neoplastic prostate 14 187
Pathologist 1
Prostatic acinar adenocarcinoma 17 1 92 0.78*** Substantial
Non-neoplastic prostate 6 65
Pathologist 2
Prostatic acinar adenocarcinoma 17 1 92 0.78*** Substantial
Non-neoplastic prostate 6 65
Pathologist 3
Prostatic acinar adenocarcinoma 21 9 88 0.71*** Substantial
Non-neoplastic prostate 2 57
FCM evaluation of prostatic biopsies compared to histopathological diagnoses, the percentage of correct diagnoses, k-value and significance for all raters and each operator.
***P < 0.001.
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The diagnostic performance was evaluated on the receiver
operating characteristic (ROC) curve and the area under the
curve (AUC). A ROC curve describes the relationship
between the sensitivity and specificity of a test. The two are
inversely related, and the plot is, therefore, a representation
of the trade-off between detecting true and false positives.
Moreover, a two-way model of interclass correlation (ICC)
was used to assess the inter-observer reliability by
comparing the variability of different ratings of the same
subject to the total variation across all ratings and all
subjects. ICC results were interpreted as: poor (˂0.5),
moderate (0.5–0.74), good (0.75–0.9) and excellent (˃0.9)
reliability [20].
For all analyses a P < 0.001 was considered statistically
significant. MedCalc Statistical Software version 14.8.1
(MedCalc Software bvba, Ostend, Belgium; http://www.
medcalc.org; 2014) and STATA program version 14




A total of 89 biopsies were collected from 13 consecutive
patients who underwent RALP at our centre. The mean (SD;
range) patient age was 63.8 (7.64; 51–75) years and the mean
(SD; range) PSA level was 9.1 (7.65; 3.2–28.0) ng/mL. Clinical
staging was T1c and T2c in 84.6% and 15.4%, respectively.
The most represented preoperative Gleason Scores were
Gleason Score 6 (Gleason Grade Group 1 [GGG1]) in seven
patients, Gleason Score 7 (3 + 4) [GGG2] in three patients,
Gleason Score 7 (4 + 3) [GGG3] in two patients, and
Gleason Score 9 (5 + 4) [GGG 5] in one patient [21]. The
median (SD; range) operative time (defined as time from
incision to suture) was 175.6 (21.8; 160–215) min. The
definitive pathological staging was pT2a, pT2b, pT2c and
pT3a in 7.7%, 7.7%, 30.8% and 53.9% of the analysed
patients, respectively. Furthermore, the most represented RP
Gleason Score was 7 (3 + 4) in six patients followed by
Gleason Score 6 in four patients, whilst, Gleason Score 7
(4 + 3), Gleason Score 8 (4 + 4) and Gleason Score 9 (5 + 4)
were reported in one patient each.
Primary endpoint
Overall diagnostic agreement between FCM and
histopathological diagnoses was substantial with a 91%
correct diagnosis (j = 0.75) and an AUC of 0.884 (95% CI
0.840–0.920), 83.33% sensitivity, and 93.53% specificity. Data
are outlined in Table 1. The relationship between the
sensitivity and specificity of overall FCM diagnosis and
histopathological diagnosis is shown in Fig. 1. The individual
diagnostic agreement was substantial for each pathologist
(Table 1).
Secondary endpoints
Table 2 shows the level of agreement for the identification of
typical malignancy features at FCM and histopathological
evaluation. The Cohen’s j statistic identified the infiltrative
pattern of glandular growth as the feature with the highest














Fig. 1 ROC curve that describes the relationship between the sensitivity
and specificity of FCM evaluation and histopathological assessment of all
three pathologists.
Table 2 AUC, sensitivity and specificity of the final diagnosis and for the pathological features for all the pathologists.
AUC SE 95% CI Sensitivity, % Specificity, %
Diagnosis
Histological/FCM 0.884 0.0247 0.840–0.920 83.33*** 93.53***
Features
Atypical glands 0.891 0.0239 0.840–0.926 83.82*** 94.47***
Enlarged nuclei 0.930 0.0195 0.892–0.957 91.80*** 94.17***
Prominent nucleoli 0.900 0.0230 0.857–0.933 92.86*** 87.11***
Infiltrative pattern of glandular growth 0.891 0.0239 0.848–0.926 83.82*** 94.47***
***P < 0.001.
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reproducibility. At ROC curve analysis, the enlarged nuclei
had the highest AUC (0.930). The feature with the greatest
sensitivity was prominent nuclei (92.86%) and the highest
specificity was identified for atypical glands and the
infiltrative pattern of glandular growth (94.47%). Figure 2
shows FCM digital images, including typical features of
cancerous and non-neoplastic tissue, in comparison with
corresponding histopathology images.
The pathologists’ level of confidence with interpreting FCM
digital imaging is reported in Fig. 3. According to the
Pearson correlation coefficient, an overall positive correlation
for all pathologists (0.536, P < 0.001) was observed (Table 3).
The inter-observer reliability, according to the ICC, was
calculated to be 0.808 (95% CI 0.725–0.869) and 0.993 (95%
CI 0.991–0.996) for FCM evaluation and histopathological
diagnosis, respectively. This outcome reflects a good
inter-observer reliability for FCM evaluation and an excellent
reliability for histopathological examination.
Discussion
Our present preliminary experience with FCM, an optical
microscopic tool that is able to analyse freshly excised
specimens at histopathological-like resolution, suggests that
prostate cancerous tissue and non-neoplastic tissue can be
intraoperatively differentially diagnosed with a high reliability
and reproducibility compared to histopathological diagnosis.
This provides a base for future researchers to explore the
potential application of this promising technology. FCM has
been previously applied to different surgical settings, such as
skin, breast, lymph node, thyroid, and colon [13], but has not
previously been applied to prostate cancer.
A substantial level of agreement (j-value = 0.75) between
FCM and histopathological examination with an AUC of
0.884, an 83.3% sensitivity, 93.5% specificity and 91%
accuracy compared to conventional histopathological
evaluation was evidenced in the present preliminary cohort of
prostate cancer samples. The neurovascular structure-adjacent
frozen-section examination (NeuroSAFE) [8] is an established
real-time approach, which has been proven to be a valid tool
for intraoperative evaluation of periprostatic tissues. Its
application on a series of 1040 patients with prostate cancer
proved a significant improvement in the rate of nerve-sparing
procedures (97% vs 81%) with a reduced PSM rate (16% vs
24%) compared to the non-NeuroSAFE group [22].
NeuroSAFE has a higher sensitivity, specificity and accuracy
compared to the results of FCM in the present preliminary
study (93.5%, 98.8%, and 97.3%, respectively) [8], but is more
time consuming, requires a dedicated team of various
specialists, and is more applicable to high-volume centres.
Comparatively, FCM sample preparation can be performed by
the treating surgeon and interpretation of digital images can
be performed by a single pathologist, also via image transfer
at an external location.
Another alternative real-time pathological analysis tool is
confocal laser endomicroscopy (CLE). Cellvizio© (Mauna Kea





Fig. 2 Shows the different FCM findings in comparison to the
histopathological evaluation; (A and B) shows the typical architecture of
the prostate gland on FCM; (C and D) shows the architecture of the
prostate gland on histopathological evaluation; (E and F) shows the
atypical growth of the prostate gland and the enlarged nuclei with
prominent nucleoli on FCM; (G and H) shows the same features on
histopathological examination.
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system, has been applied to urology both during
endourological procedures for TCC and during RP. Cellvizio
consists of fibre optic probes for image acquisition, with a
more shallow tissue penetration, a lower cell resolution and a
smaller field of view, when compared to FCM [23]. However,
it is worth mentioning that the NeuroSAFE and the Cellvizio
were used to assess surgical margins, but in the present study
random biopsies were taken from the prostate and the
margins were not assessed, as our main aim was to initially
assess the feasibility of FCM in prostatic tissue examination.
Other real-time pathological analysis of prostate cancer
samples includes video-rate structured illumination
microscopy (VR-SIM). VR-SIM is an ex vivo, wide-field
optical sectioning technique, combining the use of 4.2
megapixel, high-speed scientific complementary metal-oxide
semiconductor (CMOS) cameras and fast ferroelectric spatial
light modulators for rapid pattern switching [24]. In a study
of the pathological examination of 34 unfixed and uncut
prostate cancer core biopsies, a similar AUC (0.82–0.88), and
a lower sensitivity (62.5–87.5%), specificity (77.8–83.3%) and
accuracy (76.5–82.4%) when compared to the present study
were found [24].
Furthermore, multiphoton microscopy (MPM) has also been
previously applied to prostate cancer in a descriptive study
[25]. This imaging technology depends on the non-linear
excitation caused by the simultaneous absorption of two or
three low-energy photons, resulting in an internal optical
sectioning resolution similar to FCM, but with superior tissue
penetration. MPM was shown to be able to differentiate
between benign and malignant prostatic tissues, but specificity
and sensitivity analyses were not reported [25]. In the present
study, FCM proved capable of not only differentiating
between benign and malignant prostatic tissues, but was also





















Fig. 3 Pearson correlation coefficient showing a positive correlation between the confidence of diagnosis and the gold standard (0.536, P < 0.001).
Table 3 Frequencies, j-value, significance and reproducibility of prostatic adenocarcinoma features at FCM evaluation compared to histopathological
evaluation for all pathologists.
Features Histological evaluation Level of agreement Reproducibility
No Yes j-value
FCM evaluation Atypical glands No 188 11 0.78*** Substantial Excellent
Yes 11 57
Enlarged nuclei No 188 11 0.78*** Substantial Excellent
Yes 11 57
Prominent nucleoli No 196 29 0.64*** Substantial Good
Yes 3 39
Infiltrative pattern of glandular growth No 194 12 0.83*** Almost perfect Excellent
YES 5 56
Frequencies, j-value, significance and reproducibility of prostatic adenocarcinoma features at FCM evaluation compared to histopathological evaluation for all pathologists are
illustrated. ***P < 0.001.
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cancer, with a substantial or almost perfect level of agreement
compared to histopathological outcomes.
A simple and fast digital image acquisition with the
requirement of a short learning curve (unpresented data) are
amongst the main advantages of FCM compared to other
currently available technologies (Cellvizio, VR-SIM, and
MPM). The present study reports a high inter-observer
reliability (ICC = 0.808) and a positive correlation between
individual pathologist diagnostic confidence and
histopathological diagnoses.
The intraoperative integration of FCM analysis may offer
many advantages to the management of patients with prostate
cancer, with a real-time simplified pathological analysis
preparation and interpretation. Tissue management is
extremely fast (<5 min) compared to VR-SIM (4–5 min)
[24], Cellvizio (10 min) [23], NeuroSAFE (35 min) [8], and
MPM (<60 min) [25]. Additionally, there are no fixation
artefacts on the specimen and tissue integrity is maintained
during FCM analyses, making the sample available for
subsequent histopathological examination. However, these
results should be interpreted with caution, as our present
study did not assess the surgical margins.
Gleason Score is amongst the most important variables
predicting the outcomes and prognosis of RP. Thus, the
accurate reporting of the Gleason Score is crucial [26].
Interestingly, we tried to evaluate the ability of the FCM to
differentiate between indolent prostate cancer (Gleason Sum
≤6) and clinically significant prostate cancer (Gleason Sum
≥7) showing 78% agreement between FCM and
histopathology (j = 0.59). However, this is just a preliminary
result as it integrated only one of the three pathologists and it
was not included in the aims of the present study
(unpresented data). Currently, we have an ongoing study that
includes the assessment of Gleason Score amongst its main
endpoints.
Moreover, real-time differential identification between
cancerous tissue and non-neoplastic tissue in prostate cancer
surgery is essential but challenging. The reliability and
reproducibility of this technology for the pathological
examination of prostatic tissues reported in the present study
represents the base upon which future researches can explore
the benefits of this tool in the field of prostate cancer. In
these settings, we are planning a new study to assess the use
of the FCM in assessment of surgical margins during RALP.
The main limitation of our present study is the small sample
size, which limits the robustness of our results. Moreover, the
learning curve was not included in the aims of the present
study. The surgical margin was not assessed in the present
study, which is considered another limitation; however, this
was intentionally done as we believe that the first step before
using a new cellular imaging technology is to assess its
feasibility and ability to differentiate malignant from benign
characteristics and to ensure that it does not affect the
integrity of the specimens. Further studies are required to
confirm FCM diagnostic accuracy, create standardised FCM
reporting and assess the associated learning curve on larger
sample cohorts.
Conclusion
From our preliminary analysis, FCM seems to be a promising
tool with a high reliability and reproducibility compared to
gold standard diagnostics, offering rapid intraoperative
evaluations with limited required personnel. Further studies
are required to confirm these results and to explore the
potential applications of this technology in urology.
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microscopy; mpMRI, multiparametric MRI; NeuroSAFE,
neurovascular structure-adjacent frozen-section examination;
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laparoscopic approach to RP; ROC, receiver operating
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